Back

Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Antithrombotic therapy in acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nicolo Vasumini

University of Bologna, Bologna (Italy)

7 More presentations in this session

Presentation thumbnail
Prognostic role of PRECISE-DAPT score in acute coronary syndrome: insight from sigle centre registry
Doctor D. Bauer (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Anticoagulation for treatment of left ventricular thrombus: an systematic review and meta-analysis
Doctor I. Schmal (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
A shorter duration of dual-antiplatelet therapy for percutaneous coronary intervention following acute coronary syndrome: a meta-analysis of randomized clinical trials
Doctor S. Dasari (Bloomington, US)
Abstract Slides Video
Presentation thumbnail
Effect of P2Y12 pretreatment on angiographic findings and in-hospital mortality in patients with ST-elevation myocardial infarction
Doctor N. Vythoulkas-Biotis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
CYP2C19 genetic variants and coronary atherosclerosis: insights beyond antiplatelet therapy
Doctor S. Chiusolo (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotic therapy in acute coronary syndromes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries
thumbnail
Congress Presentation
Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis
thumbnail
Congress Presentation
Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources